Clinical Trials
7 trialsNCT00607841 2019-05-06
A Study of Ispinesib in Metastatic Breast Cancer
Cytokinetics
Phase 1 Terminated
NCT00136578 2017-09-25
Ispinesib In Combination With Carboplatin In Patients With Solid Tumors
GlaxoSmithKline
Phase 1 Completed
NCT00363272 2013-01-16
Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT00101244 2013-01-14
SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00098826 2013-01-11
SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes
National Cancer Institute (NCI)
Phase 1 Completed
NCT00119171 2008-10-16
Ispinesib In Combination With Capecitabine In Patients With Solid Tumors
GlaxoSmithKline
Phase 1 Completed
NCT00169520 2008-10-16
SB-715992 In Combination With Docetaxel In Patients With Solid Tumors
GlaxoSmithKline
Phase 1 Completed